# Ensysce Biosciences, Inc. (ENSC)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ENSC/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 1.16M | $ -6.13M | $ -5.46M | $ 196.8K | $ -781.7K |
| 2025 | $ 0 | $ -10.42M | $ -8.12M | $ 306.7K | $ 3.21M |
| 2024 | $ 0 | $ -8.39M | $ -7.89M | $ 301.7K | $ 3.71M |
| 2023 | $ 0 | $ -11.48M | $ -11.66M | $ 854.7K | $ -322.9K |
| 2022 | $ 0 | $ -27.92M | $ -19.98M | $ 4.43M | $ -3.71M |
| 2021 | $ 0 | $ -34.52M | $ -10.10M | $ 17.21M | $ -7.88M |
| 2020 | $ 1.10M | $ 72.3K | $ 172.17M | $ 4.27M | $ -6.44M |
| 2019 | $ 0 | $ 1.06M | $ 15.47M | $ 566.3K | $ 186.17M |
| 2018 | $ 0 | $ 2.80M | $ 261.9K | $ 0 | $ 5.00M |
| 2017 | $ 0 | $ -42.0K | $ -332.5K | $ 0 | $ 0 |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.25 |
| Liabilities / Eq | -5.20 |
| Current Ratio | 0.70 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / FCF | 0.01 |

## Other views

- [Metrics](https://sponda.capital/en/ENSC.md)
- [Charts](https://sponda.capital/en/ENSC/charts.md)
- [Compare](https://sponda.capital/en/ENSC/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-28.